focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,172.00
Bid: 11,500.00
Ask: 12,470.00
Change: 0.00 (0.00%)
Spread: 970.00 (8.435%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,172.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-UK shares end higher on earnings optimism; AstraZeneca gains

Tue, 16th Mar 2021 09:12

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* Just Group jumps on strong earnings
* Unite Group rises on upbeat outlook
* UBS bullish on FTSE 100 in 2021
* Midcaps end near 13-month high
* FTSE 100 up 0.8%, FTSE 250 adds 1.1%

(Updates to close)
By Shivani Kumaresan and Amal S
March 16 (Reuters) - London's FTSE 100 rose on Tuesday
following a clutch of upbeat company earnings, while AstraZeneca
rose after the European medicine watchdog said it saw little
reason to change its stance on the drugmaker's COVID-19 vaccine.
The blue-chip FTSE 100 index ended 0.8% higher at
its best close since early January, with financials, healthcare
and consumer staples stocks among the best performers.
AstraZeneca was the top boost to the index after the
European Medicines Agency (EMA) head, Emer Cooke, said she saw
no reason to change its recommendation of the vaccine. The EMA
is still investigating concerns over the shot's safety and will
release its findings on Thursday.
"The market is starting to appreciate that higher yields are
not necessarily a bad thing for stocks, as long as they reflect
higher growth and inflation expectations," said Andrea Cicione,
head of strategy at TS Lombard.
"Over the last few sessions, investors are gaining a bit
more confidence and are getting comfortable with growth again."

A recent rise in treasury yields had hampered an otherwise
strong start to the year for UK stocks, as investors feared a
bigger-than-expected spike in inflation as economies began to
reopen.
Meanwhile, brokerage UBS in a note said it remained bullish
on UK equities and raised its FTSE 100 year-end target from
7,200 to 7,600, a 17.6% premium to its 2020 close.
The energy sector was the top laggard for the day, as lower
oil prices resulted in losses in oil heavyweights BP Plc
and Royal Dutch Shell Plc .
The domestically focused FTSE 250 index rose 1.1% to
a near 13-month high, almost completely recovering its losses
from the coronavirus crisis.
Specialist pension provider Just Group Plc rose
5.2% after it reported an 11% rise in annual earnings and
flagged progress in shoring up its capital base.
Student housing provider Unite gained 2.2%, after it
forecast a return to full occupancy and rental growth for the
upcoming academic year and reinstated dividend for the
pandemic-hit 2020.

(Reporting by Shivani Kumaresan and Amal S in Bengaluru;
Editing by Arun Koyyur and Lisa Shumaker)


More News
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more
27 Mar 2024 09:03

LONDON MARKET OPEN: FTSE 100 slips as unease lingers before US data

(Alliance News) - Stock prices in London edged lower after the open on Wednesday, with some nervy trade ahead of a US inflation reading later in the week.

Read more
27 Mar 2024 08:02

LONDON BRIEFING: Diploma makes buy; Astra wins Japan drug approvals

(Alliance News) - Stocks in London opened in a muted fashion on Wednesday, with some unease lingering in equity markets ahead of a US inflation reading later in the week.

Read more
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.